300294SZSE

Explanation of Change in Independent Financial Advisor for CR Pharma's Private Placement Project

✨ AI Summary

CITIC Securities is changing the independent financial advisor for CR Pharma's private placement project. Zhao Dongtian is leaving due to personal reasons, and Fan Xinliang will replace him to continue the ongoing supervision work. The handover has been completed.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Shenzhen Stock Exchange:

CITIC Securities Co., Ltd. (hereinafter referred to as "our company") is the sponsor for China Resources Pharma Group Limited's project of issuing shares to specific objects (hereinafter referred to as "the project"), with Zhao Dongtian and Huang Jiangning as the sponsored representatives. As Zhao Dongtian has been transferred out of our company due to personal reasons, our company will appoint Fan Xinliang as the sponsored representative to succeed him in responsible for the subsequent ongoing supervision work of this project. The relevant business has been handed over.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.